Cargando…

Evaluation of analytic and clinical performance of two immunoassays for detecting thyroid‐stimulating receptor antibody in the diagnosis of Graves’ disease

OBJECTIVE: To evaluate the analytical and clinical performance of two immunoassays for diagnosis of Graves’ disease (GD), the Immulite thyroid‐stimulating immunoglobulin (TSI), and Elecsys Anti‐TSH receptor (TSHR) assay. METHODS: Precision and analytical measurement range were assessed using pooled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yao, Ni, Jiajin, Cen, Yi, Zhang, Buyue, Wu, Wenqing, Cheng, Wei, Huang, Mingying, Guan, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649345/ https://www.ncbi.nlm.nih.gov/pubmed/34752648 http://dx.doi.org/10.1002/jcla.23950

Ejemplares similares

An Immunoassay for Human Chorionic Gonadotropin in Cerebrospinal Fluid: Validation of a Modified-Approved Method for Accreditation by the College of American Pathologists
por: Hu, Yao, et al.
Publicado: (2021)

SAT-415 Clinical Performance of Thyroid-Stimulating Immunoglobulin for Graves′ Disease Diagnosis
por: Marui, Suemi, et al.
Publicado: (2020)

Evaluation of the diagnostic performance of thyroid‐stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease
por: Xu, Shiji, et al.
Publicado: (2023)

Elevated Graves’ Disease-Specific Thyroid-Stimulating Immunoglobulin and Thyroid Stimulating Hormone Receptor Antibody in a Patient With Subacute Thyroiditis
por: Alvin Mathew, Anu, et al.
Publicado: (2021)

Clinical utility of TSH receptor antibody levels in Graves’ orbitopathy: a comparison of two TSH receptor antibody immunoassays
por: Bluszcz, Gabriela A., et al.
Publicado: (2018)

An Interesting Case of Euthyroid Graves’ Ophthalmopathy, With Negative Thyroid-Stimulating Hormone Receptor Antibodies
por: Moeen, Zunera, et al.
Publicado: (2021)

Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves’ Orbitopathy
por: Khamisi, Selwan, et al.
Publicado: (2023)

Prognostic significance of thyroid-stimulating hormone receptor antibodies in moderate-to-severe graves’ orbitopathy
por: Park, Jungyul, et al.
Publicado: (2023)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

Antibodies against thyroid-stimulating hormone receptor cause maternal-neonatal transmission of Graves' Disease
por: Yu, Yue, et al.
Publicado: (2021)

Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin
por: Hu, Yao, et al.
Publicado: (2021)

Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease
por: Kwon, Hyemi, et al.
Publicado: (2016)

The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease
por: Zhou, Yulin, et al.
Publicado: (2021)

Analytical and Clinical Comparison of Two Fully Automated Immunoassay Systems for the Diagnosis of Celiac Disease
por: Lakos, Gabriella, et al.
Publicado: (2014)

SAT-422 Evaluation of the Siemens Thyroid Stimulating Immunoglobulin (TSI) Assay for Diagnosis and Prognosis of Graves’ Disease
por: Paul, Heather, et al.
Publicado: (2020)

Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
por: Padoan, Andrea, et al.
Publicado: (2020)

Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves’ disease and its relationship to the degree of hyperthyroidism
por: Liu, Tianqi, et al.
Publicado: (2022)

Evaluation of the Abbott Alinity i Thyroid-Stimulating Hormone Receptor Antibody (TRAb) Chemiluminescent Microparticle Immunoassay (CMIA)
por: Lee, Deborah J. W., et al.
Publicado: (2023)

Role of Maternal Thyroid-Stimulating Immunoglobulin in Graves' Disease for Predicting Perinatal Thyroid Dysfunction
por: Cui, Yiwen, et al.
Publicado: (2019)

The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves’ Disease
por: Cho, Sun Wook, et al.
Publicado: (2015)

The Evaluation of Analytical Performance of Immunoassay Tests by using Six-sigma Method
por: Nar, Rukiye, et al.
Publicado: (2017)

Clinical diagnosis of Graves’ or non-Graves’ hyperthyroidism compared to TSH receptor antibody test
por: Bell, Lauren, et al.
Publicado: (2018)

Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: A meta-analysis
por: Xiong, Haibo, et al.
Publicado: (2016)

Effects of glucocorticoid pulse therapy on thyroid function and thyroid antibodies in children with graves’ disease
por: Hu, Yanyan, et al.
Publicado: (2021)

Association of clinical course with thyroid-stimulating immunoglobulin in Graves’ ophthalmopathy in Mongolians
por: Bayarmunkh, Oyungerel, et al.
Publicado: (2022)

Establishment of clinical diagnosis model of Graves’ disease and Hashimoto’s thyroiditis
por: Cui, Zhaohui, et al.
Publicado: (2019)

Usefulness of Functional Thyroid-Stimulating and Thyroid-Blocking Immunoglobulin Bioassays in an Atypical Presentation of Graves’ Disease
por: Sherfan, Julie, et al.
Publicado: (2023)

Thyroid-Stimulatory Antibody as a Predictive Factor for Graves’ Disease Relapse
por: Da Silva Santos, Tiago, et al.
Publicado: (2022)

The Clinical Implications of Anti-thyroid Peroxidase Antibodies in Graves’ Disease in Basrah
por: Alhubaish, Emad S, et al.
Publicado: (2023)

Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy
por: Woo, Young Jae, et al.
Publicado: (2015)

The value of FT4/TSH ratio in the differential diagnosis of Graves’ disease and subacute thyroiditis
por: Zhang, Yingjie, et al.
Publicado: (2023)

Epitopes specificity of antibodies to thyroid peroxidase in patients with Graves’ disease, Hashimoto’s thyroiditis and overlap-syndrome
por: Espenbetova, Maira, et al.
Publicado: (2022)

Transit analysis of thyroid antibodies in graves’ disease following painless thyroiditis: a case report
por: Suto, Daisuke, et al.
Publicado: (2023)

1089. Analytical Performance of an Ultrasensitive Immunoassay for Detection of Clostridium difficile Toxins in Stool
por: Bartolome, Amelita, et al.
Publicado: (2018)

The Prediction Model Using Thyroid-stimulating Immunoglobulin Bioassay For Relapse of Graves’ Disease
por: Baek, Han-Sang, et al.
Publicado: (2022)

Thyroid Drugging in Graves' Disease
por: Chaudhuri, R. N.
Publicado: (1941)

The Correlations of Graves' Disease and Thyroiditis
por: Eason, John
Publicado: (1928)

Critical Comparison of Analytical Performances of Two Immunoassay Methods for Rapid Detection of Aflatoxin M(1) in Milk
por: Pecorelli, Ivan, et al.
Publicado: (2020)

A patient with Graves’ disease showing only psychiatric symptoms and negativity for both TSH receptor autoantibody and thyroid stimulating antibody
por: Hamasaki, Hidetaka, et al.
Publicado: (2012)

Elephantiasic Graves' Dermopathy in a Patient with Negative Thyroid-Receptor Auto-Antibodies
por: Berglund, Agnethe, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lo61s80blan7slg454t9aikkkm